Relationship Between Risk of Atherosclerotic Cardiovascular Disease, Inflammation, and Coronary Microvascular Dysfunction in Rheumatoid Arthritis

J Am Heart Assoc. 2022 Jun 7;11(11):e025467. doi: 10.1161/JAHA.121.025467. Epub 2022 Jun 3.

Authors

Affiliations

¹ Heart and Vascular Center Division of Cardiovascular Medicine Department of Medicine Brigham and Women's HospitalHarvard Medical School Boston MA.
² Division of Rheumatology, Inflammation, and Immunity Brigham and Women's Hospital Harvard Medical School Boston MA.
³ Division of Rheumatology, Allergy and Immunology Massachusetts General HospitalHarvard Medical School Boston MA.
⁴ Cardiovascular Imaging Program Division of Nuclear Medicine and Molecular Imaging Department of Radiology Brigham and Women's HospitalHarvard Medical School Boston MA.

No abstract available

Keywords: coronary microvascular dysfunction; inflammation; rheumatoid arthritis.

Publication types

Letter
Research Support, Non-U.S. Gov't
Research Support, N.I.H., Extramural

MeSH terms

Antirheumatic Agents* / therapeutic use
Arthritis, Rheumatoid* / complications
Arthritis, Rheumatoid* / drug therapy
Arthritis, Rheumatoid* / epidemiology
Cardiovascular Diseases* / drug therapy
Humans
Inflammation / drug therapy
Myocardial Ischemia* / drug therapy
Risk Factors

Substances

Antirheumatic Agents

Associated data

ClinicalTrials.gov/NCT02714881

Grants and funding